Both in Pharmaceuticals
Ionis Pharmaceuticals vs Ligand Pharmaceuticals
Over the past year IONS returned −44.0% and LGND returned +60.5%; their daily moves had a correlation of 0.19.
IONS −44.0% LGND +60.5%Growth of $1, one year, split-adjusted
| Metric | IONS | LGND |
|---|---|---|
| Price | $41.24 | $307.02 |
| Market cap | $6.85B | $6.14B |
| Today | −5.24% | −4.87% |
| 1 month | −5.3% | +1.3% |
| 6 months | −45.3% | +34.4% |
| Year to date | −47.9% | +62.4% |
| 1 year | −44.4% | +64.1% |
| Revenue growth (YoY) | −40.7% | −31.8% |
| Gross margin | 99.0% | 83.7% |
| Net margin | −42.8% | −36.2% |
| P/E (TTM) | — | 119.3× |
| Price / sales | 7.8× | 24.2× |
| Net cash | $732.0M | -$653.3M |
| Dividend yield | — | — |
| Volatility (60d) | 43.7% | 29.5% |
| Short % of float | 12.6% | 13.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).